Updated on 9 July 2014
Singapore: Singapore has been witnessing strong performance. Here are a few developments in the country that are proof to increasing its bioscience presence.
Alcon, global eye-care firm, launched an ophthalmic pharmaceutical manufacturing facility in Singapore with an investment of $159.6 million to produce ophthalmic pharmaceutical products to address eye conditions such as glaucoma, dry eye, allergies and bacterial infections.
Thermo Fisher Scientific and National University of Singapore entered into a strategic alliance to advance basic and applied research in Singapore for future discoveries and development of applications.
Global generics firm, Actavis, opened its regional office in Singapore to serve as the headquarters for the company's Asia Pacific and Africa (APACA) region.